On the other hand, in colon tumour lines, Carter et al. showed that miR-200 targeted RASSF2 mRNA with the inhibition of its expression, and tumour cells overexpressing this microRNA proliferated more [32]. The gene discussed is RASSF2; the disease is neoplasm.